Le Lézard
Classified in: Health, Covid-19 virus

Ocean Springs Pharmaceutical Company Donates N95 Masks to Firefighters Across the United States


OCEAN SPRINGS, Miss., Aug. 14, 2020 /PRNewswire-PRWeb/ -- Gulf Coast Pharmaceuticals Plus (GCPP), a leading specialty pharmaceutical distributor based in Ocean Springs, Mississippi, recently donated hundreds of N95 respirator masks to fire departments across the United States. The donation comes as firefighters and other first responders across the nation have been experiencing critical shortages of personal protective equipment (PPE) since the start of the global COVID-19 pandemic.

"Disruptions in global supply chains have caused acute nationwide shortages of N95 masks and other personal protective equipment that our first responders depend on," said GCPP Managing Director Ken Ritchey. "Our firefighters already risk their lives every day in order to save others and protect their communities, and with the current health crisis, it is even more important that we all come together to help protect those who protect us."

Gulf Coast Pharmaceuticals Plus donated the much-needed N95 face masks to the following fire departments:

Understanding how critical it is to ensure the safety and security of the nation's pharmaceutical supply chain, Gulf Coast Pharmaceuticals Plus maintains an extensive inventory of more than 25,000 types of healthcare products, including both PPE (personal protection equipment) and non-PPE supplies. Maintaining a large inventory enables GCPP to service medical facilities and first responders throughout the United States without interruptions caused by potential backorders and shortages.

Since the start of the pandemic, Gulf Coast Pharmaceuticals Plus has been donating large quantities of PPE supplies to hospitals and state-run medical facilities across the U.S., as well as to healthcare workers in the state of Mississippi where the company is headquartered.

About Gulf Coast Pharmaceuticals Plus

Gulf Coast Pharmaceuticals Plus (GCPP) is a comprehensive pharmaceutical distributor for many of the leading U.S. Pharmaceutical companies, delivering products quickly and accurately to a network of hospitals, pharmacies, and physician practices across the United States. Over the past 20 years in business, Gulf Coast Pharmaceuticals Plus has become one of the most reliable distributors of medical supplies in the nation through its quick delivery, excellent customer service, and access to over 25,000 healthcare products. Learn more about GCPP products and services at http://www.gulfcoastpharmaceuticalsplus.com, and get the latest on company news by visiting its Facebook, Twitter, and LinkedIn pages.

 

SOURCE Gulf Coast Pharmaceuticals Plus


These press releases may also interest you

at 20:09
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

at 19:30
Results  For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...

at 19:30
Lendistry announces today that it has been selected to administer the Entertainment Business Interruption Fund Program (BIF) to support small Los Angeles County businesses serving the entertainment industry. This program, created and funded through...

at 18:40
Rocky Mountain Liquor Inc. (the "Company" or "Rocky Mountain"), listed on the TSX Venture Exchange (the "Exchange"), today reported its financial results for the full year and fourth quarter ended December 31, 2023.KEY...

at 18:05
Guanajuato Silver Company Ltd. (the "Company" or "GSilver") announces a brokered, best-efforts Listed Issuer Financing Exemption private placement (the "Offering") consisting of units of the Company (the "Units") at a price of C$0.20 per Unit (the...

at 17:25
Customers Bancorp, Inc. : First Quarter 2024 Highlights Q1 2024 net income available to common shareholders was $45.9 million, or $1.40 per diluted share; ROAA was 0.94% and ROCE was 12.08%. Q1 2024 core earnings* were $46.5 million, or $1.42...



News published on and distributed by: